Neurotropism of SARS-CoV-2: COVID-19 presenting with an acute manic episode.
Jamie A MawhinneyCatherine WilcockHasan HaboubiShahbaz RoshanzamirPublished in: BMJ case reports (2020)
A 41-year-old man with no significant medical history presented with acute behavioural disruption on the background of a 1-day history of severe headache and a 10-day history of dry cough and fever. He was sexually disinhibited with pressured speech and grandiose ideas. His behaviour worsened, necessitating heavy sedation and transfer to intensive care for mechanical ventilation despite no respiratory indication. Investigations confirmed that he was positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Neuroimaging and a lumbar puncture were normal. Initial screening for SARS-CoV-2 in the cerebrospinal fluid was negative although no validated assay was available. The patient's mental state remained abnormal following stepdown from intensive care. Psychiatric assessment found features consistent with acute mania, and he was detained under the Mental Health Act. This case indicates the need to consider COVID-19 in a wider series of clinical presentations and to develop a validated assay for SARS-CoV-2 in the cerebrospinal fluid.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- respiratory failure
- mechanical ventilation
- mental health
- cerebrospinal fluid
- liver failure
- drug induced
- coronavirus disease
- bipolar disorder
- acute respiratory distress syndrome
- aortic dissection
- intensive care unit
- case report
- extracorporeal membrane oxygenation
- high throughput
- healthcare
- hepatitis b virus
- early onset
- minimally invasive
- mental illness
- ultrasound guided